New state legislatures face many continuing issues, including budget shortfalls, vaccine distribution problems and strained healthcare infrastructure. However, opportunities exist for significant policy wins for rheumatology, particularly on the issues of step therapy reform, telemedicine and copay accumulators.
Search results for: Telemedicine
Successful Resolutions, Policy Updates at AMA House of Delegates 2020 Interim Meeting
At the virtual interim meeting Nov. 13–17, the ACR delegation led a successful bid to update American Medical Association policies on home infusion and copay accumulators and supported efforts against the Most Favored Nation drug pricing model.
Winter 2021’s Awards, Appointments & Announcements in Rheumatology
New Appointments for Carlos Lozada, MD In the midst of the coronavirus pandemic, Carlos J. Lozada, MD, FACP, FACR, professor of clinical medicine, University of Miami Miller School of Medicine, has expanded his professional and volunteer duties. In May he was appointed chief (interim) of the Division of Rheumatology at the Miller School of Medicine,…
‘Communication Is More Important Than Ever’: A Q&A with Howard M. Busch, DO
As founder and president of a large rheumatology group, Howard M. Busch, DO, says the pandemic has had a limited financial effect on many of the network’s clinics. Communication and technology have been key to adapting to the needs of patients and connecting with other providers during this critical time.
Advancing the ACR’s Legislative Priorities in 2021
With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.
ACR Advocacy: 2020 Year in Review
As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.
Telerheumatology: What’s Next?
In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.
Marcus Snow, MD, FACR, Assumes Chair of the Committee on Rheumatologic Care
Marcus Snow, MD, FACR, had his first exposure to rheumatology in a rotation during his residency at the University of Nebraska Medical Center, Omaha. James O’Dell, MD, Theodore Mikuls, MD, Jay Moore, MD, Lynn Klassen, MD, and other physicians showed how rheumatology could be the perfect mix of a narrow clinical focus with interesting patient…
The Personal Side of COVID-19: A Q&A with Elna Schiopu, MD
Dr. Schiopu has experienced the COVID-19 pandemic response from both clinical and research perspectives. She recently discussed her experiences with The Rheumatologist.
9 Lessons on Patient Empowerment
ACR CONVERGENCE 2020—In her ARP keynote address on Friday, Nov. 6, Empowering Patients to Make an Impact on the Future of Healthcare, Jen Horonjeff, PhD, described a study in which researchers gathered data on pain and activity level among arthritis patients. In her view, the study provided a cautionary tale. Researchers expected the study subjects…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 19
- Next Page »